Merck & Co., Inc. (LON:0QAH)

London flag London · Delayed Price · Currency is GBP · Price in USD
78.13
-0.47 (-0.60%)
At close: Jun 5, 2025
-39.48%
Market Cap 143.38B
Revenue (ttm) 49.47B
Net Income (ttm) 13.49B
Shares Out n/a
EPS (ttm) 5.32
PE Ratio 10.63
Forward PE 8.63
Dividend 2.45 (3.14%)
Ex-Dividend Date Mar 17, 2025
Volume 5,370
Average Volume 14,428
Open 78.69
Previous Close 78.60
Day's Range 77.27 - 78.78
52-Week Range 73.30 - 134.62
Beta 0.44
RSI 48.59
Earnings Date Jul 29, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janu... [Read more]

Sector Healthcare
Founded 1891
Employees 75,000
Stock Exchange London Stock Exchange
Ticker Symbol 0QAH
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.